Stenting of the iliac arteries with the Palmaz stent: experience from a multicenter trial.
Balloon-expandable, intraluminal stenting of the iliac arteries with the Palmaz stent was the subject of a multicenter study for 4 years. A total of 486 patients underwent 587 procedures. Four hundred and five patients had unilateral and 81 had bilateral iliac stent placements. Follow-up ranged from 1 to 48 months (mean 13.3 +/- 11 months). Sustained clinical benefit of the treated patients was obtained in 90.9% at 1 year, 84.1% at 2 years, and 68.6% at 43 months. Angiographic patency rate was 92%. Diabetes mellitus and poor runoff had significant negative influence on the clinical outcome. The 10% incidence of procedural complications was not altered by operator experience.
Palmaz
J C
JC
Department of Radiology, University of Texas Health Science Center, San Antonio 78284.
Laborde
J C
JC
Rivera
F J
FJ
Encarnacion
C E
CE
Lutz
J D
JD
Moss
J G
JG
D001161:Arteriosclerosis / Q000000981:diagnostic imaging / Q000453:epidemiology / Q000628:therapy*; D004867:Equipment Design; D005260:Female; D005500:Follow-Up Studies; D006801:Humans; D007083:Iliac Artery; D008297:Male; D008875:Middle Aged; D011859:Radiography; D012307:Risk Factors; D015607:Stents / Q000009:adverse effects; D013997:Time Factors; D014654:Vascular Patency / Q000502:physiology